Fig. 6From: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effectFT-IR spectrum of carvedilol (a), phospholipid (b), cholesterol (c), ethosomal suspension (d), Carbopol-934 (e), and ethosomal gel (f)Back to article page